Aurobindo Pharma, a manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, has received final approval for Fosinopril Sodium and Hydrocholorothizide Tablets USP 10/12.5 mg and 20/12.5 mg from the US Food and Drug Administration (USFDA).

These bicalutamide tablets, USP 50 milligram are therapeutically equivalent to Casodex tablets from AstraZeneca Casodex tablets have annual sales of approximately $314 million in the US.

India's Sun Pharmaceutical Industries Ltd (SUN.BO) said on Tuesday it had received approval from the U.S. Food and Drug Administration to launch generic version of AstraZeneca Plc's (AZN.L) prostate cancer drug Casodex.

Sun Pharmaceutical Industries Ltd announced the receipt of a tentative approval from US FDA for Sun Pharma's Abbreviated New Drug Application (ANDA) for generic Optivar, azelastine ophthalmic solution, 0.05%.